News
Vaccine may double survival in patients with deadly brain tumors A vaccine aimed at inducing immunity to the most common and deadly type of brain tumor may stave off recurrence and more than double survival in patients, according to a new study led by researchers in Duke`s Preston Robert Tisch Brain Tumor Center.
|